1-13 of 13
David Stover
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2650: Ags67e, an anti-cd37 monomethyl auristatin e antibody (mmae) drug conjugate as a potential therapeutic for non-hodgkin's lymphoma, chronic lymphocytic leukemia and acute myeloid leukemia

Daniel S. Pereira, Claudia Guevara, Alla Verlinsky, Cyrus Virata, J Hsu Ssucheng, Zili An, Chungying Zhang, Nick Dinh, Hector Avina, Lisa Do, Sher Karki, Joseph Abad, Peng Yang, Jimmy Ou, Karen Morrison, Sing-Ju Moon, Faisal Malik, Liqing Jin, Michael Choi, Christina Wu, Banmeet Anand, Scott Cooper, Ingrid Joseph, Xiao-Chi Jia, Kendall Morrison, Pia Challita-Eid, Fernando Donate, Thomas Kipps, John Dick, David Stover
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2650.
https://doi.org/10.1158/1538-7445.AM2014-2650
Published: 01 October 2014
View article titled, Abstract 2650: Ags67e, an anti-cd37 monomethyl auristatin e antibody (mmae) drug conjugate as a potential therapeutic for non-hodgkin's lymphoma, chronic lymphocytic leukemia and acute myeloid leukemia
Journal Articles

Abstract 2047: Discovery and molecular characterization of AGS-15/SLITRK6 as a novel target for antibody-mediated therapeutic development in bladder cancer.

Yuriy Shostak, Suzanne Said, Deanna L. Russell, Michael D. Mattie, Mi Sook Chang, Ashley Christensen, Karen Morrison, Kendall Morrison, David Stover, Pia Challita-Eid
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2047.
https://doi.org/10.1158/1538-7445.AM2013-2047
Published: 15 April 2013
View article titled, Abstract 2047: Discovery and molecular characterization of AGS-15/SLITRK6 as a novel target for antibody-mediated therapeutic development in bladder cancer.
Journal Articles

Abstract 1274: SLITRK6, the target of a novel antibody drug conjugate AGS15E, is expressed in bladder and other cancers.

Peng YANG, Jeffrey Coleman, Ying Li, Yi Zhang, Candice Junge, Kendall Morrison, Fernando Donate, David Stover, Karen Morrison
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1274.
https://doi.org/10.1158/1538-7445.AM2013-1274
Published: 15 April 2013
View article titled, Abstract 1274: SLITRK6, the target of a novel antibody drug conjugate AGS15E, is expressed in bladder and other cancers.
Journal Articles

Abstract 1314: Molecular profiling and characterization of patient-derived human pancreatic tumor xenograft models, and application for drug discovery and preclinical development of cancer therapeutics

Michael D. Mattie, Mi Sook Chang, Ashley Christensen, William Yeh, Suzanne Said, Yuriy Shostak, Linnette Capo, Alla Verlinsky, Zili An, Sathish Kumar-Ganesan, Karen Morrison, Ingrid Joseph, David Stover, Pia Challita-Eid
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1314.
https://doi.org/10.1158/1538-7445.AM2012-1314
Published: 15 April 2012
View article titled, Abstract 1314: Molecular profiling and characterization of patient-derived human pancreatic tumor xenograft models, and application for drug discovery and preclinical development of cancer therapeutics
Journal Articles

Abstract 3853: TAS266, a novel tetrameric nanobody agonist targeting death receptor 5 (DR5), elicits superior antitumor efficacy than conventional DR5-targeted approaches

Heather Huet, Alwin Schuller, Jing Li, Jennifer Johnson, Bruno Dombrecht, Kris Meerschaert, Karen Cromie, Sanela Bilic, Sharon Li, Andrew Garner, Sandra Nunes, Rajiv Chopra, Kirk Clark, Megan Yao, Stephen Fawell, David Stover, William R. Sellers, Seth Ettenberg
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3853.
https://doi.org/10.1158/1538-7445.AM2012-3853
Published: 15 April 2012
View article titled, Abstract 3853: TAS266, a novel tetrameric nanobody agonist targeting death receptor 5 (DR5), elicits superior antitumor efficacy than conventional DR5-targeted approaches
Journal Articles

Abstract 1086: Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression

Nandini Rudra-Ganguly, Daulet Satpayev, Christine Lowe, Liping Hu, Bally Randhawa, Mi Sook Chang, Alla Verlinsky, Jeffrey Coleman, Pia Challita-Eid, Peng Yang, Zili An, Karen Morrison, Art Raitano, Daniel S. Pereira, David Stover
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1086.
https://doi.org/10.1158/1538-7445.AM2012-1086
Published: 15 April 2012
View article titled, Abstract 1086: Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression
Journal Articles

Abstract 4566: AGS-1C4D4: A fully human anti-PSCA antibody inhibits tumor formation and metastasis in orthotopic models of pancreatic cancer

Tony Navas, Trisha Haubrich, Jenny Llamas, Hector Avina, Zhang Chunying, Myra Perez, Linnette Capo, Monica Leavitt, Rou-Yu Chen, Alla Verlinsky, Zili An, James Secrest, Nandini Ganguly, Daulet Satpayev, Karen Morrison, Art Raitano, Pia Challita-Eid, Xiao-Chi Jia, Kendall Morrison, Alan Hartford, David Stover
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4566.
https://doi.org/10.1158/1538-7445.AM2011-4566
Published: 15 April 2011
View article titled, Abstract 4566: AGS-1C4D4: A fully human anti-PSCA antibody inhibits tumor formation and metastasis in orthotopic models of pancreatic cancer
Journal Articles

Abstract 2832: Development of AGS-22M6E, a novel antibody drug conjugate (ADC) targeting Nectin-4 for the treatment of solid tumors

Daulet Satpayev, Michael Torgov, Peng Yang, Karen Morrison, Yuriy Shostak, Art Raitano, Wendy Liu, Dawn Lortie, Zili An, Linnette Capo, Monica Leavitt, Myra Perez, Alla Verlinsky, Kenna Shirasuna, Hector Avina, Claudia Guevara, Kendall Morrison, Pia Challita-Eid, Xiao-Chi Jia, Jean Gudas, David Stover
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2832.
https://doi.org/10.1158/1538-7445.AM2011-2832
Published: 15 April 2011
View article titled, Abstract 2832: Development of AGS-22M6E, a novel antibody drug conjugate (ADC) targeting Nectin-4 for the treatment of solid tumors
Journal Articles

BHQ880, a novel anti-DKK1 neutralizing antibody, inhibits tumor-induced osteolytic bone disease

Seth Ettenberg, Feng Cong, Janine Shulok, Stefanie Urlinger, Michael Bardroff, Olga Charlat, Yuji Mishina, Shanming Liu, Michael Daley, Sharon Li, Renee Walsh, Georges Rawadi, Philippe Clement-Lacroix, Patrick Mollat, Youzhen Wang, Yung-Mae Yao, David Stover
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3987.
Published: 01 May 2008
View article titled, BHQ880, a novel anti-DKK1 neutralizing antibody, inhibits tumor-induced osteolytic bone disease
Journal Articles

Antitumor efficacy of LBY135, an anti-DR5 monoclonal antibody, alone or in combination with chemotherapy in human colon tumor cell lines and xenografts

Jing Li, Betty Tang, Jean Cheng, Joseph Eckman, Christine Miller, Jing Yuan, Youzhen Wang, Deborah Knee, Quinn Deveraux, Marc Nasoff, David Stover
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4874.
Published: 01 May 2007
View article titled, Antitumor efficacy of LBY135, an anti-DR5 monoclonal antibody, alone or in combination with chemotherapy in human colon tumor cell lines and xenografts
Journal Articles

Elevated DKK-1 levels in lytic prostate cancer cell line conditioned medium and   prostate cancer patient serum.

Kim Leitzel, Seth Ettenberg, Renee Walsh, David Stover, Vijay Modur, Edgar Braendle, Dean Evans, Laurence Demers, Suhail Ali, Luis Costa, Allan Lipton
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2665.
Published: 01 May 2007
View article titled, Elevated DKK-1 levels in lytic prostate cancer cell line conditioned medium and   prostate cancer patient serum.
Journal Articles

Tumor-cell specific cytotoxic activity of LBY135, a novel anti- DR5 agonistic antibody

Jing Li, Qingxiu Zhang, Jennifer Johnson, Deborah Knee, Quinn Deveraux, Marc Nasoff, David Stover
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4875.
Published: 01 May 2007
View article titled, Tumor-cell specific cytotoxic activity of LBY135, a novel anti- DR5 agonistic antibody
Journal Articles

PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration

Jeanette M. Wood, Guido Bold, Elizabeth Buchdunger, Robert Cozens, Stefano Ferrari, Jörg Frei, Francesco Hofmann, Jürgen Mestan, Helmut Mett, Terence O’Reilly, Elke Persohn, Johannes Rösel, Christian Schnell, David Stover, Andreas Theuer, Harry Towbin, Fritz Wenger, Kathie Woods-Cook, Andreas Menrad, Gerhard Siemeister, Michael Schirner, Karl-Heinz Thierauch, Martin R. Schneider, Joachim Drevs, Georg Martiny-Baron, Frank Totzke, Dieter Marmé
Journal: Cancer Research
Cancer Res (2000) 60 (8): 2178–2189.
Published: 01 April 2000
View article titled, PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration
Open the PDF for PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration in another window